Subsequent AS01-adjuvanted vaccinations induce similar transcriptional responses in populations with different disease statuses.
Ontology highlight
ABSTRACT: Transcriptional responses to adjuvanted vaccines can vary substantially among populations. Interindividual diversity in levels of pathogen exposure, and thus of cell-mediated immunological memory at baseline, may be an important determinant of population differences in vaccine responses. Adjuvant System AS01 is used in licensed or candidate vaccines for several diseases and populations, yet the impact of pre-existing immunity on its adjuvanticity remains to be elucidated. In this exploratory post-hoc analysis of clinical trial samples (clinicalTrials.gov: NCT01424501), we compared gene expression patterns elicited by two immunizations with the candidate tuberculosis (TB) vaccine M72/AS01, between three groups of individuals with different levels of memory responses to TB antigens before va
SUBMITTER: Coccia M
PROVIDER: S-EPMC9648731 | biostudies-literature | 2022
REPOSITORIES: biostudies-literature
ACCESS DATA